 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT
Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2019 June;178(6):466-8
DOI: 10.23736/S0393-3660.18.03786-5
Copyright © 2018 EDIZIONI MINERVA MEDICA
language: English
Cannabinoid-induced toxic hepatitis
Gulperi KESKIN 1, Nafiye URGANCI 2 ✉
1 Department of Pediatrics, Sisli Etfal Training and Research Hospital, Istanbul, Turkey; 2 Division of Pediatric Gastroenterology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey
The use of synthetic cannabinoids is increasing, especially among teenagers and young adults worldwide. Their most commonly observed adverse effects involving the gastrointestinal system are nausea, vomiting, abdominal pain, diarrhea, weight loss and rarely hepatotoxicity. Herein, we report two cases aged 16- and 17-year-old admitted to our pediatric emergency department with cannabinoid-induced toxic hepatitis and recovered spontaneously. Synthetic cannabinoids should be kept in mind in the differential diagnosis of the toxic hepatitis.
KEY WORDS: Cannabinoids; Chemical and drug induced liver injury; Child